Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × ruxolitinib × Myeloid × Clear all

Status

Completed 29 Recruiting 14 Active not recruiting 12 Terminated 9 Unknown 3 Withdrawn 2 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

nilotinib 2 venetoclax 1 ruxolitinib 1 ponatinib 1 navitoclax 1 midostaurin 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05269771 2025-11-05

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Novartis

No longer available

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡